Zephyrnet Logo

Alvotech, AbbVie Deal Allows For Humira Biosimilar In 2023

Date:

Icelandic biopharmaceutical firm Alvotech has settled an intellectual property fight with AbbVie Inc. over Alvotech’s proposed biosimilar version of AbbVie’s blockbuster drug Humira, which is used to treat arthritis and other conditions.

spot_img

Latest Intelligence

spot_img